REGISTER
How to systematically construct a comprehensive treatment pathway
Prof. Jin and Prof. Trapani discussed how to systematically construct a comprehensive treatment pathway for advanced triple-negative breast cancer (TNBC) centered on sacituzumab govitecan.

Prof. Juan Jin, Fudan University Shanghai Cancer Center, China
Prof. Dario Trapani, European Institute of Oncology, Italy

Prof. Jin and Prof. Trapani discussed how to systematically construct a comprehensive treatment pathway for advanced triple-negative breast cancer (TNBC) centered on sacituzumab govitecan, based on findings from the ASCENT-04 and ASCENT-03 studies. They explored how treatment selection and adjustment can be individualized according to patients’ baseline clinical conditions, and shared perspectives on the differences between Chinese and international patients in developing personalized treatment strategies.

0
0
Loading